Talha Ahmed, Ibrahim Mohammed
Department of Surgery, Medical Research Institute, Alexandria University, 165, Al-Horreya Avenue, Hadara, Alexandria, 21561, Egypt.
Obes Surg. 2018 Feb;28(2):437-443. doi: 10.1007/s11695-017-2862-8.
Gastroesophageal reflux disease (GERD) is commonly associated with obesity, and its surgical management is debatable.
The objective of this study was to prove the safety and feasibility of laparoscopic Nissen's fundoplication (LNF) combined with mid-gastric plication (MGP) for treatment of obese patients with GERD.
LNF combined with MGP was done for 18 patients. All interventions were performed under general anesthesia. The follow-up protocol included body mass index (BMI), percentage of excess weight loss (%EWL), percentage of excess BMI loss (%EBMIL), and clinical assessment using the Gastro-esophageal Reflux Health-Related Quality-of-Life (GERD-HRQOL) scale at 6 and 12 months.
The period of follow-up ranged from 12 to 33 months with a mean of 17.74 ± 3.73 months. The operation time was 1.40 ± 0.27 h. No serious procedure-related complications occurred. GERD-related symptoms resolved in all patients (p < 0.001). There was a significant improvment in endoscopic findings at 6 months compared to properatively (p = 0.001). There was a significant patient satisfaction score using GERD-HRQOL at 6 and 12 months (p = 0.000). The 1-year follow-up excess weight was significantly less than the baseline excess weight (p < 0.001). The average BMI decreased from 37.59 ± 1.89 kg/m at baseline to 30.61 ± 1.57 kg/m at 1 year (p < 0.001).
LNF combined with MGP for treatment of obese patients with GERD is technically safe, feasible, and promising with no serious procedure-related complications. The technique is effective in terms of weight loss and cure of GERD. However, future larger studies are required to demonstrate the safety, effectiveness, and long-term durability of the procedure.
胃食管反流病(GERD)通常与肥胖相关,其手术治疗存在争议。
本研究的目的是证明腹腔镜尼氏胃底折叠术(LNF)联合胃中部折叠术(MGP)治疗肥胖GERD患者的安全性和可行性。
对18例患者实施LNF联合MGP。所有干预均在全身麻醉下进行。随访方案包括体重指数(BMI)、超重减轻百分比(%EWL)、超重BMI减轻百分比(%EBMIL),以及在6个月和12个月时使用胃食管反流健康相关生活质量(GERD-HRQOL)量表进行临床评估。
随访时间为12至33个月,平均为17.74±3.73个月。手术时间为1.40±0.27小时。未发生严重的手术相关并发症。所有患者的GERD相关症状均得到缓解(p<0.001)。与术前相比,6个月时内镜检查结果有显著改善(p = 0.001)。在6个月和12个月时,使用GERD-HRQOL量表的患者满意度得分显著(p = 0.000)。1年随访时的超重体重显著低于基线超重体重(p<0.001)。平均BMI从基线时的37.59±1.89kg/m²降至1年时的30.61±1.57kg/m²(p<0.001)。
LNF联合MGP治疗肥胖GERD患者在技术上是安全、可行且有前景的,无严重的手术相关并发症。该技术在减重和治愈GERD方面有效。然而仍需要未来更大规模的研究来证明该手术的安全性、有效性和长期耐久性。